Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-UMIN000009411
JPRN-UMIN000009411
Completed
未知

The efficacy of rituximab for children with refractory nephrotic syndrome - Rituximab for children with refractory nephrotic syndrome

Department of Pediatrics, Kobe University Graduate School of Medicine0 sites20 target enrollmentDecember 1, 2012
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionssteroid dependent nephrotic synrdome and frequent relapsing nephrotic syndrome

Overview

Phase
未知
Intervention
Not specified
Conditions
steroid dependent nephrotic synrdome and frequent relapsing nephrotic syndrome
Sponsor
Department of Pediatrics, Kobe University Graduate School of Medicine
Enrollment
20
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 1, 2012
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Department of Pediatrics, Kobe University Graduate School of Medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •steroid resistant nephrotic syndrome

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 3
Early rituximab treatment in children with idiopathic nephrotic syndrome Eng. ERICONS - Early RITUXIMAB in Childhood Onset Nephrotic Syndrome
2024-515058-26-00Medical University Of Gdansk60
Completed
Not Applicable
Rituximab in pediatric rheumatic diseases: 2 years follow up for immunological long-term effects using a standardized screening and safety protocol.M08.0M32.1Juvenile rheumatoid arthritisSystemic lupus erythematosus with organ or system involvement
DRKS00020514(Non-profit) Verein: Hilfe für das rheumakranke Kind e.V.21
Active, not recruiting
Phase 1
Efficacy and safety of rituximab in the treatment of good prognosis microscopic polyangiitis
EUCTR2018-000637-12-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)106
Completed
Phase 2
The efficacy of rituximab for recalcitrant Pemphigus Vulgaris in the patients of Razi hospital from 2007 to 2011Pemphigus vulgaris.Pemphigus vulgaris
IRCT201111022704N2Vice-chancellor for Research of Tehran University of Medical Sciences40
Completed
Not Applicable
A study of the efficacy and safety to rituximab in treating adult onset refractory nephrotic syndromeRefractory nephrotic syndrome
JPRN-UMIN000021143Fujita Health University School of Medicine, Department of Nephrology10